Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tris Pharma logo — Passion. Drive. Innovation.

Tris Pharma

Passion. Drive. Innovation.

Founded 2000 United States United States 433 employees Grant Total: $141.60M Biotechnology, Life Sciences +2

General Information

Company Name Tris Pharma
Founded Year 2000
Location United States United States
Founders / Decision Makers
Team member
Employees 433
Industries Biotechnology, Life Sciences, Manufacturing +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Tris Pharma. To contact Tris Pharma, visit trispharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Tris Pharma

Tris Pharma is a privately-owned biopharmaceutical company, founded in 2000, with a focus on developing and commercializing innovative medicines to address unmet patient needs. The company holds more than 150 U.S. and International patents including applications and operates in the United States. Their portfolio includes branded and generic products and they have a robust pipeline of innovative products, particularly in neuroscience and other therapeutic categories. Tris Pharma's unique science and technology, coupled with its team of approximately 500 diverse individuals, sets them apart. The company emphasizes the importance of respectful, open, and honest communications to support individual and team success. Their last investment of $16.60MGrant came on 28 August 2023 from the National Institute on Drug Abuse (NIDA). The company's commitment to diversity and inclusion, as well as sustained culture, adds to their potential for growth and success.

Taxonomy: biopharmaceutical company, innovative medicines, patents, proprietary science, neuroscience, diverse team, culture, Diversity & Inclusion, Women’s Business Council, team collaboration, company success, engagement, communication, commercialization, drug development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $16.60M 1
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
28 Aug 2023
Debt Financing $125.00M 1
Deerfield
05 Oct 2018

Tris Pharma Alternatives & Competitors

View All Alternatives
Tris Pharma vs
AVEO Oncology
AVEO Oncology United States

Committed to delivering medicines that provide a better life for patients with cancer.

Post-IPO Equity
197 employees
Biotechnology, Health Care
Tris Pharma vs
Eton Pharmaceuticals
Eton Pharmaceuticals United States

Rare diseases call for a rare company.

Post-IPO Equity
39 employees
Biopharma, Biotechnology
Tris Pharma vs
Akelos Inc
Akelos Inc United States

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited Investors -...

Grant
5 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Tris Pharma

Passion. Drive. Innovation.
Tris Pharma was founded in 2000.
Tris Pharma is headquartered in United States.
Tris Pharma operates in Biotechnology, Life Sciences, Manufacturing and Pharmaceutical. Its work centres on biopharmaceutical company, innovative medicines, patents and proprietary science.
Tris Pharma has approximately 433 employees.
Tris Pharma has completed 2 funding rounds, raising a total of $141.60M. The latest funding stage is Grant.
Top alternatives and competitors to Tris Pharma include AVEO Oncology, Eton Pharmaceuticals, Akelos Inc, InnoCare Pharma, Synthego. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tris Pharma and AVEO Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tris Pharma, https://bouncewatch.com/company/tris-pharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes